Nov 17, 2021· Comment from Consumer Healthcare Products Association· FDA-2020-D-2316-0009
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2020-D-2316
Benefit-Risk Assessment for New Drug and Biological Products; Draft Guidance for Industry; Availability
RIN
—
Last modified
Oct 20, 2023
Comment window
closed 1702d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Nov 17, 2021 and Nov 17, 2021. 0 other organizations filed here. The comment window closed 1702d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%